biotech / news / / Reuters
Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations.
Sixteen major pharmaceutical firms agreed to match U.S. drug prices to those in developed countries.
KEY POINTS
- The TrumpRx.gov platform will enable direct-to-consumer sales of discounted drugs from participating companies.
- Novo Nordisk will reduce Ozempic and Wegovy prices to $350 monthly through TrumpRx, down from $1,000-$1,350.
- Bristol Myers Squibb will provide Eliquis to Medicaid for free and donate seven tons of its active ingredient.
- Regeneron is the only large pharmaceutical company yet to sign an agreement, though negotiations continue.
COMPANIES
Summarized by Newsio from Reuters. How we summarize →